DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids
Nucleic Acids Research · 25.01.2024 · 52 (2) · 801-815
DOI: 10.1093/nar/gkad1119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.11.2023. Verfasst von Kang Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: ADP-Ribosylation, Nucleic Acids, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Although ubiquitylation had traditionally been considered limited to proteins, the discovery of non-proteinaceous substrates (e.g. lipopolysaccharides and adenosine diphosphate ribose (ADPr)) challenged this perspective. Our recent study showed that DTX2 E3 ligase efficiently ubiquitylates ADPr. Here, we show that the ADPr ubiquitylation activity is also present in another DELTEX family member, DTX3L, analysed both as an isolated catalytic fragment and the full-length PARP9:DTX3L complex, suggesting that it is a general feature of the DELTEX family. Since structural predictions show that DTX3L possesses single-stranded nucleic acids binding ability and given the fact that nucleic acids have recently emerged as substrates for ADP-ribosylation, we asked whether DELTEX E3s might catalyse ubiquitylation of an ADPr moiety linked to nucleic acids. Indeed, we show that DTX3L and DTX2 are capable of ubiquitylating ADP-ribosylated DNA and RNA synthesized by PARPs, including PARP14. Furthermore, we demonstrate that the Ub-ADPr-nucleic acids conjugate can be reversed by two groups of hydrolases, which remove either the whole adduct (e.g. SARS-CoV-2 Mac1 or PARP14 macrodomain 1) or just the Ub (e.g. SARS-CoV-2 PLpro). Overall, this study reveals ADPr ubiquitylation as a general function of the DELTEX family E3s and presents the evidence of reversible ubiquitylation of ADP-ribosylated nucleic acids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Orléans, France.
- Department of Biomedicine, University of Bergen, Bergen, Norway.
- Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge MA 02140, USA.
ORCID-Profile: Marcin J Suskiewicz, Ivan Ahel
Förderung
- Wellcome Trust
- Cancer Research UK
- Biotechnology and Biological Sciences Research Council
- Ovarian Cancer Research Alliance
- Oxford University Challenge Seed Fund
- Cancer Research United Kingdom
- Edward Penley Abraham Research Fund
- EU
Zitieren
APA
Zhu, K., Suskiewicz, M. J., Chatrin, C., Strømland, Ø., Dorsey, B. W., Aucagne, V., Ahel, D., & Ahel, I. (2024). DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. Nucleic Acids Research, 52(2), 801-815. https://doi.org/10.1093/nar/gkad1119
Vancouver
Zhu K, Suskiewicz MJ, Chatrin C, Strømland Ø, Dorsey BW, Aucagne V, et al. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. Nucleic Acids Research. 2024;52(2):801-815. doi:10.1093/nar/gkad1119
BibTeX
@article{Zhu2024,
author = {Zhu, Kang and Suskiewicz, Marcin J and Chatrin, Chatrin and Strømland, Øyvind and Dorsey, Bryan W and Aucagne, Vincent and Ahel, Dragana and Ahel, Ivan},
title = {DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {2},
pages = {801--815},
doi = {10.1093/nar/gkad1119}
}
EUVIMED